Skip to main content
Premium Trial:

Request an Annual Quote

Diversa Awarded $1.38M for Proteomics-based Biodefense Research

NEW YORK, June 16 - Diversa will receive $1.38 million from the Department of Defense's chemical and biological defense initiatives fund for proteomics-related biodefense research, the San Diego-based microbial genomics firm said today.


The award will support the development of diagnostic and therapeutic antibodies against anthrax as well as the identification of new targets associated with anthrax and plague pathology, the company said.


The DOD funds will be applied to three projects at Diversa: the identification of an optimized antibody against anthrax; proteomics analysis of blood serum from the survivors of the fall 2001 anthrax attacks to identify novel targets for therapeutics; and the proteomics-based Identification of novel protein targets associated with plague.


The company said its proteomics analysis method relies on 3D liquid chromatography directly coupled with tandem mass spectroscopy.


The research is part of Diversa's "Rapid, Antibody-Based Biological Countermeasures" (RABBC) biodefense program, which aims to develop a collection of novel human antibodies for diagnostic detection and immunity protection against pathogens and toxins. 

The Scan

Driving Malaria-Carrying Mosquitoes Down

Researchers from the UK and Italy have tested a gene drive for mosquitoes to limit the spread of malaria, NPR reports.

Office Space to Lab Space

The New York Times writes that some empty office spaces are transforming into lab spaces.

Prion Pause to Investigate

Science reports that a moratorium on prion research has been imposed at French public research institutions.

Genome Research Papers on Gut Microbe Antibiotic Response, Single-Cell RNA-Seq Clues to Metabolism, More

In Genome Research this week: gut microbial response to antibiotic treatment, approach to gauge metabolic features from single-cell RNA sequencing, and more.